Gut dysbiosis and mortality in hemodialysis patients
Little is known about the relationship between gut dysbiosis, inflammation, and adverse outcomes in patients with chronic kidney disease. We examined the association of microbial diversity with all-cause mortality in hemodialysis patients. The gut microbiota was assessed by 16S ribosomal RNA gene sequencing. During a median follow-up of 2.1 years, the adjusted risk of death among patients with higher diversity (above median) was 74% lower than that among patients with lower diversity (below median). We then compared the microbial composition between nonsurvivors and survivors in a matched case-control study. We observed significantly lower microbial diversity and higher proinflammatory cytokines among nonsurvivors than survivors. Specifically, the relative abundance of Succinivibrio and Anaerostipes, two short-chain fatty acid-producing bacteria, was markedly reduced in nonsurvivors. Thus, a unique gut microbial composition is associated with an increased risk of mortality among hemodialysis patients and may be used to identify subjects with a poor prognosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
NPJ biofilms and microbiomes - 7(2021), 1 vom: 03. März, Seite 20 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Ting-Yun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 22.09.2021 Date Revised 29.01.2023 published: Electronic Dryad: 10.5061/dryad.k3j9kd55d Citation Status MEDLINE |
---|
doi: |
10.1038/s41522-021-00191-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322159733 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322159733 | ||
003 | DE-627 | ||
005 | 20231225181437.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41522-021-00191-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1073.xml |
035 | |a (DE-627)NLM322159733 | ||
035 | |a (NLM)33658514 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lin, Ting-Yun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Gut dysbiosis and mortality in hemodialysis patients |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.09.2021 | ||
500 | |a Date Revised 29.01.2023 | ||
500 | |a published: Electronic | ||
500 | |a Dryad: 10.5061/dryad.k3j9kd55d | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Little is known about the relationship between gut dysbiosis, inflammation, and adverse outcomes in patients with chronic kidney disease. We examined the association of microbial diversity with all-cause mortality in hemodialysis patients. The gut microbiota was assessed by 16S ribosomal RNA gene sequencing. During a median follow-up of 2.1 years, the adjusted risk of death among patients with higher diversity (above median) was 74% lower than that among patients with lower diversity (below median). We then compared the microbial composition between nonsurvivors and survivors in a matched case-control study. We observed significantly lower microbial diversity and higher proinflammatory cytokines among nonsurvivors than survivors. Specifically, the relative abundance of Succinivibrio and Anaerostipes, two short-chain fatty acid-producing bacteria, was markedly reduced in nonsurvivors. Thus, a unique gut microbial composition is associated with an increased risk of mortality among hemodialysis patients and may be used to identify subjects with a poor prognosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a RNA, Ribosomal, 16S |2 NLM | |
700 | 1 | |a Wu, Ping-Hsun |e verfasserin |4 aut | |
700 | 1 | |a Lin, Yi-Ting |e verfasserin |4 aut | |
700 | 1 | |a Hung, Szu-Chun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t NPJ biofilms and microbiomes |d 2015 |g 7(2021), 1 vom: 03. März, Seite 20 |w (DE-627)NLM252718763 |x 2055-5008 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2021 |g number:1 |g day:03 |g month:03 |g pages:20 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41522-021-00191-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2021 |e 1 |b 03 |c 03 |h 20 |